InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by Lyu Aifeng, 管理人员. Director active across 1 company, notably Hansoh Pharmaceutical Group Co. Ltd.. Aggregated, 7 disclosures have been logged. Activity tracked since 20 April 2026. The latest transaction was filed on 27 June 2026 (Other). Regulator: HKEX. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Lyu Aifeng is a Dirigeant and a director of Hansoh Pharmaceutical Group Co. Ltd. In total, 7 filings have been recorded, and across the 7 most recent filings available, the period runs from 2026-04-23 to 2026-06-30, with EUR 0 of purchases and EUR 1290484 of sales.